Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$75,000.00
Sep 18, 2023
For-profit organization
Japan MNE-Development of a novel product optimizing cell production steps and quality for regenerative medicine applications
1011338
The project will combine the technologies of the Firm and its Japanese partner to develop a new product improving cell production steps and quality of cells for regenerative medicine applications. Working in close collaboration with the partner, the Firm will proceed with the experimental demonstration of an optimal combination product, select the go-to-market strategy and advance agreements for its commercial implementation.
$217,500.00
May 10, 2021
For-profit organization
Accelerating Manufacturing Quality and Clinical Performance of Cell Therapies
972290
The firm will manufacture its cell conditioning product and use it to develop proof-of-concept (PoC) studies for its clients. Success of this objective will lead to R&D contracts and licensing agreements between parties.
$3,000.00
Feb 23, 2021
For-profit organization
CanExport Innovation - Targa Biomedical inc. 2020-2021
7428325 P010347001
The purpose of this CanExport Innovation grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
$1,295.96
Oct 7, 2020
For-profit organization
CanExport Innovation - Targa Biomedical inc. 2020-2021
7423923 P009884001
The purpose of this CanExport Innovation grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
$9,079.00
Dec 24, 2019
For-profit organization
CanExport Innovation - Recipient Name 2019-2020
7415530 P008735001
The purpose of this CanExport Innovation grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
$8,665.00
Sep 25, 2019
For-profit organization
CXI - Targa Biomedical Inc. 2019-2020
7412437 P008277001
The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.